Funding for this research was provided by:
Listed in the manuscript
Received: 9 September 2020
Accepted: 17 November 2020
First Online: 1 March 2021
Ethics approval and consent to participate
: The trial was approved by the Regional Ethics Committee of the Capital Region of Denmark (H-2–2011-056) and the Danish Data protection agency (2013–41-1710). The law regarding the handling of personal data was respected. Prior to commencement the trials were registered at ClinicalTrials.gov (NCT01446406). The electronic data collected from the smartphones were stored at a secure server at Concern IT, Capital Region, Denmark (I-suite number RHP-292 2011–03). The trial complied with the Helsinki Declaration of 1975, as revised in 2008.
: MFJ, AN, and NRJ have no conflicts of interest. VGF has served on advisory boards for Sage Therapeutics and received honorarium for lectures at Lundbeck Pharma. MV has been consultant for Lundbeck Pharma, Janssen and Sunovion. LVK has been consultant for Lundbeck within the last three years.